Tianhong Xu

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Systemic Lupus Erythematosus

Multiple Myeloma

Binding Protein

Top Venues

Cancer medicine

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu
Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study. Cancer medicine (2023)
Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu
Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study. Cancer medicine 13 (1) (2023)
Yang Yang, Jing Li, Wenjing Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Xianmuseye Aihemaiti, Feifei Chen, Tianhong Xu, Jiadai Xu, Peng Liu
The evolving diagnosis and treatment paradigms of multiple myeloma in China: 15 years' experience of 1256 patients in a national medical center. Cancer medicine (2023)
Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu
Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study. Cancer medicine (2023)
Wenjing Wang, Jing Li, Yang Yang, Feifei Chen, Tianhong Xu, Pu Wang, Yawen Wang, Aziguli Maihemaiti, Liang Ren, Tianwei Lan, Panpan Li, Chi Zhou, Peng Liu
Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study. Cancer medicine (2023)
Jifeng Jiang, Yifeng Sun, Jiadai Xu, Tianhong Xu, Zhao Xu, Peng Liu
ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma. Cancer medicine 9 (19) (2020)
Jiadai Xu, Tianhong Xu, Yang Yang, Wenjing Wang, Jing Li, Yuhong Ren, Shiyang Gu, Chen Chen, Zheng Wei, Jingli Zhuang, Zhimei Wang, Lili Ji, Luya Cheng, Weiguang Wang, Zhixiang Cheng, Yang Ke, Ling Yuan, Peng Liu
The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides. Leukemia & lymphoma 61 (10) (2020)